NEW YORK, July 7 - Bioinformatics startup Ocimum Biosolutions said today that it is collaborating with the Hospital of Joint Diseases at New York University's School of Medicine to analyze musculoskeletal disease data.
Ocimum will use its microarray analysis software Genowiz in the project.
Financial terms and other details of the project were not disclosed.